Filing Details
- Accession Number:
- 0000313143-12-000239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-05 14:03:49
- Reporting Period:
- 2012-12-03
- Filing Date:
- 2012-12-05
- Accepted Time:
- 2012-12-05 14:03:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1261784 | Brian Concannon | 400 Wood Road Braintree MA 02184 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-03 | 3,000 | $26.38 | 119,286 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-03 | 3,000 | $40.75 | 116,286 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-12-03 | 10,000 | $11.32 | 126,286 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-03 | 10,000 | $40.75 | 116,286 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-12-03 | 10,000 | $0.00 | 10,000 | $11.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-12-03 | 3,000 | $0.00 | 3,000 | $26.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,000 | 2004-09-15 | 2013-09-15 | No | 4 | M | Direct |
| 9,288 | 2007-05-05 | 2013-05-05 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | $13.05 | 2005-05-05 | 2014-05-05 | 30,000 | 30,000 | Direct |
| Common Stock | Non-Qualified Stock Option (right to buy) | $25.54 | 2008-10-24 | 2014-10-24 | 45,780 | 45,780 | Direct |
| Common Stock | Non-Qualified Stock Option (right to buy) | $26.47 | 2010-10-27 | 2016-10-27 | 159,350 | 159,350 | Direct |
| Common Stock | Non-Qualified Stock Option (right to buy) | $27.28 | 2009-10-22 | 2015-10-22 | 57,176 | 57,176 | Direct |
| Common Stock | Non-Qualified Stock Option (right to buy) | $27.50 | 2011-10-27 | 2017-10-27 | 236,750 | 236,750 | Direct |
| Common Stock | Non-Qualified Stock Option (right to buy) | $27.69 | 2010-04-02 | 2016-04-02 | 65,690 | 65,690 | Direct |
| Common Stock | Non-Qualified Stock Option (right to buy) | $30.67 | 2012-10-25 | 2018-10-25 | 219,572 | 219,572 | Direct |
| Common Stock | Non-Qualified Stock Option (right to buy) | $39.06 | 2013-10-24 | 2019-10-24 | 250,382 | 250,382 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2014-05-05 | 30,000 | 30,000 | Direct |
| 2014-10-24 | 45,780 | 45,780 | Direct |
| 2016-10-27 | 159,350 | 159,350 | Direct |
| 2015-10-22 | 57,176 | 57,176 | Direct |
| 2017-10-27 | 236,750 | 236,750 | Direct |
| 2016-04-02 | 65,690 | 65,690 | Direct |
| 2018-10-25 | 219,572 | 219,572 | Direct |
| 2019-10-24 | 250,382 | 250,382 | Direct |
Footnotes
- Pursuant to a 10b5-1 Plan.
- Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Billionaire Hedge Funds
